Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Nordic Nanovector ASA Webcast to Discuss the Merger Transcript

Nov 24, 2022 / 03:30PM GMT
Release Date Price: kr1.12 (+17.71%)
Jan Hendrik Egberts
Nordic Nanovector ASA - Independent Chairman of the Board

Good afternoon, ladies and gentlemen. Welcome to the joint webcast between Nordic Nanovector and APIM, where we would like to discuss the proposed merger between our 2 companies. My name is Jan Egberts, and I'm the Chairman of the Board of Nordic Nanovector.

Together with me this afternoon are Malene Brondberg, our Interim CFO; as well as Kostas Alevizopoulos, who is the CEO of APIM Therapeutics and the proposed CEO for the combined entity; as well as Fredrik Haavind, our internal Chief Legal Counsel.

Over the past couple of weeks, frankly, since before the announcement of the proposed merger, we have spoken with many of you. We received a lot of different e-mails, but we also had one-on-one meetings, in particular with the largest shareholders, where we basically heard that particularly APIM is not very well known, and people like to hear more about it, and that's the objective of this call to tell you a little bit about more about APIM and also explain to you a little bit about the proposed transactions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot